Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as C$0.12 and last traded at C$0.11, with a volume of 453968 shares. The stock had previously closed at C$0.11.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The stock has a market cap of C$47.72 million, a PE ratio of -3.96 and a beta of 0.88. The firm has a fifty day moving average price of C$0.07 and a 200 day moving average price of C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- How to Invest in Biotech Stocks
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Growth Stocks: What They Are, What They Are Not
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Differences Between Momentum Investing and Long Term Investing
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
